FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792162017> ?p ?o ?g. }

• W2792162017 endingPage "313" @default.
• W2792162017 startingPage "308" @default.
• W2792162017 abstract "Genetic risk factors could cause cutaneous adverse drug reactions (cADRs) in patients after treatment with clarithromycin. This study explored the association of HLA class I genes with clarithromycin-cADRs in Han Chinese patients. A total of 12 clarithromycin-cADR patients and 34 clarithromycin-tolerant controls were recruited for the high-resolution genotyping of HLA class I genes (HLA-A, HLA-B and HLA-C). The population controls consisted of 283 Han Chinese retrieved from the MHC database for validated comparison. A molecular docking analysis of HLA-A*02:07 protein and clarithromycin was conducted using glide module with Schrödinger Suite. Among all tested HLA alleles, the carrier frequencies of HLA-A*02:07 (58% versus 5.9%, OR = 22.40, 95% CI = 3.58-139.98, p = 8.20 × 10E-5, pc = 1.1 × 10E-3) and HLA-B*46:01 (50% versus 5.9%, OR = 16.00, 95% CI = 2.59-98.99, p = 0.002, pc = 0.03) were significantly higher in clarithromycin-cADRs than in clarithromycin-tolerant controls. However, when compared to population controls, only HLA-A*02:07, and not HLA-B*46:01, reached statistical significance (58% versus 15.5%, OR = 7.61, 95% CI = 2.31-25.04, p = 1.2 × 10E-4, pc = 1.7 × 10E-3). Furthermore, molecular docking data revealed that clarithromycin could bind to and interact with HLA-A*02:07 in two possible binding situations. These data suggest that HLA-A*02:07 might be a genetic risk factor for developing clarithromycin-cADRs in Han Chinese and serve as a useful biomarker for personalized medicine to prevent clarithromycin-cADRs." @default.
• W2792162017 created "2018-03-29" @default.
• W2792162017 creator A5002251300 @default.
• W2792162017 creator A5012189725 @default.
• W2792162017 creator A5020081826 @default.
• W2792162017 creator A5025647936 @default.
• W2792162017 creator A5034315050 @default.
• W2792162017 creator A5050429307 @default.
• W2792162017 creator A5054634161 @default.
• W2792162017 creator A5062026165 @default.
• W2792162017 creator A5076929994 @default.
• W2792162017 creator A5078776978 @default.
• W2792162017 creator A5081711940 @default.
• W2792162017 creator A5081725636 @default.
• W2792162017 date "2018-04-25" @default.
• W2792162017 modified "2023-10-13" @default.
• W2792162017 title "<i>HLA-A*02:07</i> Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients" @default.
• W2792162017 cites W1831705392 @default.
• W2792162017 cites W1965012404 @default.
• W2792162017 cites W1983783995 @default.
• W2792162017 cites W1991864978 @default.
• W2792162017 cites W2009107589 @default.
• W2792162017 cites W2020667562 @default.
• W2792162017 cites W2070926663 @default.
• W2792162017 cites W2087088313 @default.
• W2792162017 cites W2092546907 @default.
• W2792162017 cites W2104951811 @default.
• W2792162017 cites W2112182958 @default.
• W2792162017 cites W2118424747 @default.
• W2792162017 cites W2140735648 @default.
• W2792162017 cites W2158079639 @default.
• W2792162017 cites W2170468317 @default.
• W2792162017 cites W2170575307 @default.
• W2792162017 cites W2529410280 @default.
• W2792162017 cites W2537680985 @default.
• W2792162017 cites W2554958497 @default.
• W2792162017 cites W2620846174 @default.
• W2792162017 doi "https://doi.org/10.1111/bcpt.13011" @default.
• W2792162017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29575644" @default.
• W2792162017 hasPublicationYear "2018" @default.
• W2792162017 type Work @default.
• W2792162017 sameAs 2792162017 @default.
• W2792162017 citedByCount "5" @default.
• W2792162017 countsByYear W27921620172018 @default.
• W2792162017 countsByYear W27921620172019 @default.
• W2792162017 countsByYear W27921620172021 @default.
• W2792162017 countsByYear W27921620172022 @default.
• W2792162017 crossrefType "journal-article" @default.
• W2792162017 hasAuthorship W2792162017A5002251300 @default.
• W2792162017 hasAuthorship W2792162017A5012189725 @default.
• W2792162017 hasAuthorship W2792162017A5020081826 @default.
• W2792162017 hasAuthorship W2792162017A5025647936 @default.
• W2792162017 hasAuthorship W2792162017A5034315050 @default.
• W2792162017 hasAuthorship W2792162017A5050429307 @default.
• W2792162017 hasAuthorship W2792162017A5054634161 @default.
• W2792162017 hasAuthorship W2792162017A5062026165 @default.
• W2792162017 hasAuthorship W2792162017A5076929994 @default.
• W2792162017 hasAuthorship W2792162017A5078776978 @default.
• W2792162017 hasAuthorship W2792162017A5081711940 @default.
• W2792162017 hasAuthorship W2792162017A5081725636 @default.
• W2792162017 hasBestOaLocation W27921620171 @default.
• W2792162017 hasConcept C104317684 @default.
• W2792162017 hasConcept C126322002 @default.
• W2792162017 hasConcept C135763542 @default.
• W2792162017 hasConcept C147483822 @default.
• W2792162017 hasConcept C180754005 @default.
• W2792162017 hasConcept C188280979 @default.
• W2792162017 hasConcept C203014093 @default.
• W2792162017 hasConcept C2776409635 @default.
• W2792162017 hasConcept C2776962512 @default.
• W2792162017 hasConcept C2908647359 @default.
• W2792162017 hasConcept C31467283 @default.
• W2792162017 hasConcept C37463918 @default.
• W2792162017 hasConcept C54355233 @default.
• W2792162017 hasConcept C71924100 @default.
• W2792162017 hasConcept C86803240 @default.
• W2792162017 hasConcept C99454951 @default.
• W2792162017 hasConceptScore W2792162017C104317684 @default.
• W2792162017 hasConceptScore W2792162017C126322002 @default.
• W2792162017 hasConceptScore W2792162017C135763542 @default.
• W2792162017 hasConceptScore W2792162017C147483822 @default.
• W2792162017 hasConceptScore W2792162017C180754005 @default.
• W2792162017 hasConceptScore W2792162017C188280979 @default.
• W2792162017 hasConceptScore W2792162017C203014093 @default.
• W2792162017 hasConceptScore W2792162017C2776409635 @default.
• W2792162017 hasConceptScore W2792162017C2776962512 @default.
• W2792162017 hasConceptScore W2792162017C2908647359 @default.
• W2792162017 hasConceptScore W2792162017C31467283 @default.
• W2792162017 hasConceptScore W2792162017C37463918 @default.
• W2792162017 hasConceptScore W2792162017C54355233 @default.
• W2792162017 hasConceptScore W2792162017C71924100 @default.
• W2792162017 hasConceptScore W2792162017C86803240 @default.
• W2792162017 hasConceptScore W2792162017C99454951 @default.
• W2792162017 hasFunder F4320321001 @default.
• W2792162017 hasIssue "3" @default.
• W2792162017 hasLocation W27921620171 @default.
• W2792162017 hasLocation W27921620172 @default.
• W2792162017 hasOpenAccess W2792162017 @default.

• next